Accessibility options |

New treatment trial for Vascular Dementia

19 Feb 2015

Do you have a diagnosis of mixed or vascular diagnosis?

Despite being the second most common type of dementia, there are currently no effective treatments available for vascular dementia. It is estimated that 150,000 people in the UK have vascular dementia.

We now have a treatment trial looking at vascular dementia. This trial is jointly funded by the Alzheimer’s society and British Heart Foundation and is a big step forward. If successful, the trial could provide a new treatment in as little as five years.

People taking part in the trial will either receive amlodipine – a medicine commonly used to treat high blood pressure – or a placebo pill for one year and will be monitored over two years. The researchers will test whether people taking amlodipine show any improvements in memory and thinking compared to the people taking the placebo pill.

Dr Vanessa Raymont, who is leading on the study said: “West London Mental Health Trust are pleased to be a part of this very important study. This is our first study involving patients with a diagnosis of Vascular Dementia and we hope the results of this trial will have a real impact on the lives of people living with this diagnosis.

The trial has generated a lot of interest already amongst patients, family members and our colleagues in the trust. We would be pleased to speak to anybody who is interested in hearing more about this study.”

If you would like to speak to us about participating in this study, please contact the Clinical Trials Unit on 020 8483 1833 or email Sarah Gregory: Sarah.Gregory@wlmht.nhs.uk

We’re changing the way some of our services are delivered during the coronavirus (Covid-19) public health emergency.Find out more
+ +